Open access peer-reviewed chapter

Tropical and Vectors-Borne Diseases: Insights into Biology, Transmission, and Control Measures

Written By

Rowaida Bakri and Renad J. Jadkarim

Submitted: 01 October 2024 Reviewed: 22 October 2024 Published: 28 January 2025

DOI: 10.5772/intechopen.1007959

Chapter metrics overview

311 Chapter Downloads

View Full Metrics

Abstract

Tropical and subtropical areas are flourishing environments for many unique pathogens. This chapter discusses vectors of medical importance and the vector-borne diseases of the highest burden in morbidity and mortality globally. Vectors types, characteristics, lifecycle, distribution, diseases they transmit, and their prevention and control strategies are overviewed. The discussion extends to cover key medically important vectors, including mosquitoes, ticks, flies, and fleas, highlighting their roles in disease transmission. Further, vector-borne diseases of high significance are explained in detail from a public health perspective, with the historical perspective of vectors and their transmitted illnesses. Insight of the current climate change, globalization, urbanization, and ease of international travel which contributed to the spread, expansion, and resurge of many vector-borne diseases; this chapter underscores the significance and burden of vector-borne diseases and the critical need for integrated control strategies that combine biological insights with environmental management.

Keywords

  • global health
  • public health
  • neglected tropical diseases
  • vector-borne disease
  • mosquito-borne diseases
  • prevention and control

1. Introduction

Tropical and subtropical diseases have been eliminated from most of the developed world as a result of urbanization and the availability of resources and means, allowing rigorous prevention and control efforts implementation and maintenance. Unfortunately, poverty has been a driving factor for these illnesses to thrive. Thus leaving communities located within disadvantaged countries lacking proper access and availability of needed infrastructures, means, and expertise required to mitigate tropical and subtropical diseases still struggling to this time from many of these illnesses. Among these illnesses are vector-borne diseases, accounting for a significant proportion of the global mortality and morbidity burden of infectious diseases. A comprehensive exploration in this chapter for vectors and vector-borne diseases aims to provide insights into the complex interactions between vectors, pathogens, and hosts, laying the groundwork for their effective control and prevention measures [1].

Advertisement

2. Vectors

2.1 Vectors definition and types

Vectors are organisms responsible for transferring infectious agents from one host to another [1]. These vectors fall into two broad categories: arthropods and vertebrates. Arthropods, which are the most associated with medical importance, include various invertebrates such as mosquitoes, fleas, flies, ticks, mites, and crustaceans like cyclops [2, 3]. On the other hand, vertebrates, although less commonly, can also act as vectors. Examples include rodents spreading hantavirus and animals such as bats and dogs that transmit rabies [4].

Vectors play an essential role in the spread and transmission dynamics of infectious diseases, particularly in regions with tropical and subtropical climates (Figure 1).

Figure 1.

Global map of main vector-borne diseases distribution [5].

2.2 Vectors life cycle

To design effective prevention and control strategies for vector-borne diseases, it is crucial to understand the biology and life cycles of medically significant vectors. The arthropod life cycle consists of several stages, with each stage’s involvement in disease transmission differing based on the species. Typically, the life cycle (Figure 2) progresses through the following stages:

  • Egg: Laid by the adult female arthropod in environments like vegetation or stagnant water.

  • Larva or Nymph: This stage emerges after hatching from the egg and feeds on organic materials. It undergoes several molts before advancing to the next stage.

  • Pupae: A dormant phase during which metamorphosis occurs.

  • Adult: The mature, reproductive phase that plays the primary role in spreading diseases, depending on the species, through actions such as biting or defecating [7, 8].

Figure 2.

Mosquito life cycle and different developmental stages [6].

Different developmental stages offer specific opportunities for targeted control and intervention measures [9].

2.3 Vectors characteristics

Several factors influence how effectively a vector can transmit infectious agents. These include the vector’s anatomy, reproductive processes, behavior, competence, and environmental influences. Anatomical adaptations often equip vectors with specialized tools for disease transmission. For example, the mosquito’s mouth parts are designed with sharp blades that pierce the skin of hosts, allowing them to feed on blood and spread pathogens [10]. The concept of vector competence refers to a vector’s inherent ability to acquire, harbor, and transfer a disease-causing agent [11]. This competence can differ significantly between species [12]. Additionally, many vectors have high reproductive rates and short life cycles, enabling the rapid spread of infections. Behavioral patterns, such as feeding habits, preferred environments, and mating behaviors, also influence the likelihood of disease transmission. Environmental factors such as rainfall, temperature, altitude, and humidity shape where vectors thrive, determining the areas where vector-borne diseases are likely to become endemic and cause substantial health impacts [8, 12].

Advertisement

3. Medically important vectors

3.1 Medically significant vectors

The role vectors play in transmitting infectious agents significantly contributes to the global burden of morbidity and mortality, particularly in tropical and subtropical regions. Understanding the characteristics of medically important vectors is crucial for developing effective disease prevention and control strategies. Examples of these arthropod vectors include mosquitoes, ticks, fleas, and flies [1].

3.2 Mosquitoes

Mosquitoes belong to the kingdom Animalia, phylum Arthropoda, class Insecta, and order Diptera. They are scientifically classified under the family Culicidae [13]. There are over 3000 species of mosquitoes, but only a small fraction act as vectors for pathogens. Despite their small numbers, mosquitoes are considered the deadliest animals on Earth, responsible for over one million deaths annually due to the infections they transmit [14]. The most significant mosquito species from a public health perspective belong to the genera Anopheles, Aedes, and Culex. These genera are major contributors to the spread of viral and parasitic diseases globally (Table 1).

GroupGenusDiseases
Order diptera
Family CulicidaeAnophelesMalaria
MosquitoesLymphatic filariasis (Wuchereria)
CulexLymphatic filariasis
AedesLymphatic filariasis
Yellow fever
MansoniaLymphatic filariasis (Brugia)
Family PsychodidaePhlebotomusLeishmaniasis
SandfliesLutzomyia
Psychodopygus
Family SimuliidaeSimuliumOnchocerciasis (Ozzardi filariasis)
Simuliids
Family CeratopogonidaeCulicoidesOzzzardi filariasis
CeratoponidsPerstans filariasis
Stretocerciasis
Family GlossinidaeGlossinaSleeping sickness
Tsetse flies
Family TabanidaeChrysopsLoiasis
Tabanid files
Order Siphonaptera
Family PulicidaePediculusEpidemic typhus
LiceTrench fever
Epidemic replacing fever
Order Anoplura
Family PediculidaeXenopsyllaPlague
FleasEndemic typhus
Dwarf tapeworm
CtenocephalidesDog tapeworm
Order Hemiptera
Family Reduviidae
Triatomine bugsTritomaChagas’ disease
Rhodnius
Panstrongylus

Table 1.

Overview of diseases transmitted by vectors: table provides a summary of various vector-borne diseases, highlighting vectors’ group classifications and diseases primary vectors [15].

Mosquitoes breed in various water surfaces depending on the species. Anopheles mosquitoes breed in shallow streams and creeks, Aedes prefer artificial water containers, and Culex lay their eggs on stagnant or freshwater surfaces [8].

Anopheles mosquitoes consist of over 400 species, with only 40 responsible for transmitting the malaria-causing Plasmodium parasites [16]. These mosquitoes prefer to feed on humans, typically biting at dawn, dusk, and night. Anopheles species vary in competence and geographical distribution, with An. gambiae (Figure 3) being the most competent malaria vector in sub-Saharan Africa [16]. In Latin America, An. darlingi is the primary vector, while in Asia, An. dirus, An. minimus, and An. punctulatus play significant roles making it more complex to control malaria in endemic Asian regions [16].

Figure 3.

Anopheles gambiae adult female mosquito feeding on a blood meal [17].

Aedes species transmit viruses such as dengue, Zika, yellow fever, and chikungunya. The two most medically significant species are Aedes aegypti (Figure 4) and Aedes albopictus (Figure 5). These mosquitoes are aggressive daytime feeders and are distributed across tropical and subtropical regions, favoring urban environments. Aedes mosquitoes have spread worldwide through commercial trade, such as tire shipments [9, 20].

Figure 4.

Aedes aegypti adult female mosquito in resting state [18].

Figure 5.

Aedes albopictus adult female mosquito preparing to initiate a blood meal [19].

Culex mosquitoes are found globally, except in extreme temperature regions. Culex quinquefasciatus is common in tropical and subtropical regions, including North America (Figure 6). They transmit West Nile virus, St. Louis encephalitis, Japanese encephalitis, Rift Valley fever, and filariasis. Culex mosquitoes feed on humans, animals, and birds, crucial in transmitting diseases like the West Nile virus [22].

Figure 6.

Culex adult female mosquito [21].

3.3 Ticks

Ticks are second only to mosquitoes in public health significance, serving as vectors for various pathogens, including bacteria, viruses, and protozoa. Controlling ticks is critical for global health. There are over 900 tick species, with 28 known to transmit pathogens to humans. Ticks are divided into soft (family Argasidae) and hard ticks (family Ixodidae), with hard ticks being the most significant to human health. Notable hard tick species include the black-legged tick (Ixodes scapularis) are responsible for Lyme disease spread; the American dog tick (Dermacentor variabilis) transmits Rocky Mountain spotted fever and tularemia; and the lone star tick (Amblyomma americanum) transmits ehrlichiosis [23].

Similarly, soft ticks play a significant role in transmitting multiple infections. Ornithodoros transmits tick-borne relapsing fever, and the fowl tick (Argas reflexus) affects both humans and poultry. Ticks thrive in warmer climates, and their distribution has expanded due to climate change, urbanization, and international travel [11].

3.4 Flies

There are over 150,000 species of flies worldwide. Key species of medical significance include the house fly (Musca domestica), the tsetse fly (Glossina spp.), and the sandfly. House flies, common in urban areas, spread bacterial and viral pathogens, leading to gastroenteritis [7]. Furthermore, flies larvae (maggots) can cause myiasis over open wounds and vulnerable populations as children. Tsetse flies are vectors of the protozoan parasite Trypanosoma brucei, which causes African sleeping sickness, a disease that can result in severe neurological damage [10]. Sandflies transmit Leishmania parasites. In the Old World (Africa, Asia, and Europe), sandflies belong to the Phlebotomus genus, while the Lutzomyia species are found in the Americas as a new world (Figure 7) [25].

Figure 7.

Adult Phlebotomus papatasi sand fly which completed a blood meal [24].

3.5 Fleas

Fleas are insects that inhabit various hosts, including domestic animals like cats and dogs, as well as wildlife. They prefer warm, humid environments. Fleas can transmit multiple pathogens, most notably the bacterium Yersinia pestis, which causes bubonic plague [26]. Fleas also transmit Rickettsia typhi from rats, causing murine typhus, and serve as intermediate hosts for the parasitic tapeworm Dipylidium caninum [27]. Furthermore, fleas can act as ectoparasites, causing tungiasis as it borrows through the patient’s skin, especially around the feet [28].

Advertisement

4. Vectors as diseases transmitters

Vectors are considered one of the most common causes of disease distribution worldwide. They cause diseases by transmitting the pathogens by direct infection through inoculation into human or animal tissues or indirectly acting as an intermediate host [29, 30].

The epidemiological triangle sets a conceptual framework explaining mechanisms by which vectors transmit diseases depending on the interactions between different species of the vector, pathogen, and host. Disease transmission occurs through two main mechanisms: mechanical and biological [30].

4.1 Mechanical transmission

In most cases, vectors transfer pathogens externally from one host to another without being involved in the pathogens’ life cycle. House flies are notorious as mechanical vectors for transmitting bacteria, viruses, and protozoa. Mechanical vectors are insects with body specifications that facilitate the transmission, including the internal and external anatomical structures of the vector’s body. Mechanical transmission also relies on the biological characteristics of different phases of the vector emerging during its lifecycle and its feeding habits, allowing direct and indirect contact with the pathogen and host. Mechanical transmission mode is suitable for pathogens that can survive temporarily on the surface of the vector’s body. For example, house flies can carry pathogens such as Amoeba, Escherichia coli, and Salmonella when they land on contaminated matter and food, causing foodborne diseases [29].

4.2 Biological transmission

It occurs when the vector acts as an essential host for the pathogen’s life cycle, which involves a more complex interaction between the vector and the pathogen. In biological transmission, pathogens require the vector to complete its life cycle; in the vector’s absence, the pathogen would die or be incapable of development. Pathogens undergo several sexual and asexual developmental and reproductive changes toward completing their lifecycle and becoming infectious agents before being transmitted to a new host [29, 30]. Biological transmission includes inoculating the pathogen by vector directly into the host’s bloodstream; malaria, dengue, and Zika are excellent examples. In some infections, vectors regurgitate the pathogen during feeding, like in plague disease, where fleas regurgitate Yersinia pestis into the host’s bloodstream. Biological transmission also can occur when the pathogen directly deposits on the host’s skin or mucous membranes. For example, in Chagas disease, the Trypanosoma cruzi parasite is excreted by kissing bugs in the feces and then enters the host through broken skin or mucous membranes [29].

4.3 Historical background of vectors-borne diseases

In 1878, Patrick Manson observed that mosquitoes that fed on blood from infected people with elephantiasis carried the same unsheathed microfilariae he had seen in the blood of infected people. Later, he observed that those mosquitoes were intermediate hosts for the filarial parasite Wuchereria bancrofti. Later, in 1899, Thomas Bancroft confirmed that Wuchereria bancrofti transmitted filariasis to humans through their bites [31].

Mosquitoes transmitting malaria were discovered in 1884 by Ronald Ross and other investigators under the direction of Giovanni Grassi. In 1880 and 1900, respectively, Carlose Finally and Walter Reed proved that the mosquito Aedes aegypti was responsible for yellow fever transmission [31].

In 1881, while investigating an outbreak of yellow fever in Havana, Cuba, Dr. King observed similarities between the symptoms of yellow fever and dengue and their transmission. Later, in 1906, the observation was confirmed after a dengue outbreak in the Philippines [32].

4.4 Vector-borne diseases overview

Mosquitoes are considered one of the world’s most widespread and deadly disease vectors. They develop in various aquatic habitats and in all climates, from the Arctic to the Tropics, and they are responsible for transmitting a wide range of debilitating and deadly tropical diseases, especially in poor and limited healthcare-resource countries [31]. Malaria, dengue fever, Zika, Chikungunya, Yellow fever, Rift Valley fever, and West Nile viral infection are mosquito-borne illnesses that pose a severe threat to human health worldwide [33, 34, 35].

Malaria is the most significant tropical disease transmitted by mosquitoes. Anopheles mosquitoes, particularly the female anopheline species, are the definitive host of the causative agent, the protozoan malaria parasite that belongs to the Plasmodium genus. Among the Plasmodium genus, P. falciparum and P. vivax are responsible for more than 95% of infections worldwide. Species of P. vivax are the widest-spreading species among the tropics, subtropics, and temperate regions, while P. falciparum is widely distributed in the tropics [33, 34].

The mosquito becomes infected when feeding on the blood of an infected human, where the sexual development of the parasite takes place in the mosquito’s gut before migrating to the salivary glands. In the next mosquito bite, malaria sporozoites are regurgitated from the salivary gland into another human’s bloodstream, initiating a new infection [35]. Malaria symptoms are rhythmic fever, chills, fatigue, headache, and, in severe cases, organ failure, coma, and death. Malaria is an endemic disease in many tropical and subtropical regions, particularly in sub-Saharan Africa, Southeast Asia, and parts of South America [33, 34, 35, 36].

Dengue fever is another significant global health concern carried by mosquitoes and is a widely spreading disease. Incidences of dengue have grown dramatically in recent decades, with an estimated 390 million infections occurring annually [37]. In 2015, Brazil recorded over 1.5 million dengue cases and about 500 deaths. Aedes mosquitoes are the common dengue fever vector, mainly Aedes aegypti and Aedes albopictus. These mosquitoes prosper in tropical and subtropical regions usually breeding in sluggish water sources and artificial water containers [37, 38].

There are four serotypes of dengue virus, and individuals infected with one serotype have a lifelong immunity to that specific serotype but not to the others [37]. The infection occurs through the bite of infected Aedes mosquitoes, leading to a range of non-fatal symptoms such as high fever, severe headaches, muscle and joint pain, and skin rash, also known as ‘break-bone fever.’ Subsequent infections with multilabel dengue serotypes elevate the risk of life-threatening dengue hemorrhagic fever. In severe cases, infection leads to plasma leakage, hemorrhage, and organ impairment [37].

Zika is a reemerging flavivirus infection carried by Aedes mosquitoes. Zika virus raised a significant public health concern due to its association with congenital Zika syndrome, fetal neurological complications, and severe impact on pregnant women’s well-being. Like dengue, the Zika virus transmits to humans through subsequent bites of an infected mosquito [39]. Most Zika virus infections in immunocompetent individuals are asymptomatic or mild, characterized by rash and joint pain. For several decades, Zika virus infection remained in Africa and Asia. Later, between 1969 and 1983, the geographical distribution expanded to equatorial Asia, with the virus being detected in mosquitoes and sporadic human cases reported in other countries like India, Indonesia, Malaysia, and Pakistan as a result of international travel mainly [39].

Chikungunya is a mosquito-borne viral infection, like dengue and Zika; it transmits through Aedes mosquitoes (Aedes aegypti and Aedes albopictus). Chikungunya is a tropical and subtropical disease, particularly in parts of Africa, Asia, and the Indian subcontinent. In the twenty-first century, chikungunya invaded the Americas and Europe due to outbreaks and spread of the Aedes mosquitoes. Chikungunya Infection is mild; symptoms include rash, sudden fever, headache, muscle pain, and severe joint pain [31].

Yellow fever is one of the most severe and widespread viral infections transmitted by bites of Aedes mosquitoes. Naturally, the yellow fever virus infects animals, particularly monkeys, and the viral infection is maintained in the monkey-to-monkey sylvatic cycle by forest-dwelling mosquitoes. When the sylvatic cycle is interfered with by human actions such as forest demolition and destruction, the natural cycle of forest mosquitoes is disturbed, and humans get bitten by one of the monkeys’ feeding mosquitoes [31]. Afterwhich, infected humans carry the infection to urban areas Ae. aegypti initiates the person-to-person urban cycle. Yellow fever causes severe hemorrhagic conditions symptomatized by high fever, jaundice, and prostration. The disease is geographically distributed through Africa and sub-Saharan Africa regions, where about 90% of worldwide cases were reported. Yellow fever was also found in Brazil, Peru, Colombia, Bolivia, Venezuela, and South America [31].

Rift Valley fever is a viral zoonotic disease that mainly affects livestock but also can infect humans. Viruses transmit via bites of infected mosquitoes. Aedes mosquito species are the primary vectors, but Culex species can transmit the virus too [40]. Infection is found particularly in Africa and parts of the Middle East, and the transmission to humans occurs during or shortly after periods of heavy rainfall and flooding, which create favorable breeding conditions for mosquitoes and, therefore, their abundance. In humans, the disease causes flu-like symptoms, and in severe cases, it may lead to hemorrhagic fever, encephalitis, or blindness [41].

West Nile viral infection is primarily associated with birds. It is transmitted through the bite of infected Culex mosquitoes, carrying the virus when feeding on infected birds. In the human population, this infection is asymptomatic or mild, flu-like symptoms. However, in rare cases, it can lead to serious neurological complications such as encephalitis or meningitis. West Nile virus spread throughout Africa, the Americas, and Europe [31].

Japanese encephalitis is a mosquito-borne viral disease in Asia and Western Pacific. It is a serious infection transmitted to humans via the bite of infected Culex mosquitoes, particularly Cx. tritaeniorhynchus. In most cases, the infection is asymptomatic or presents mild symptoms. In a few cases, encephalitis develops, and the patient may have paralysis, seizures, or, in worst cases, death [31, 42].

4.5 Other tropical diseases of medical important

Chagas disease, known as American trypanosomiasis, is a potentially life-threatening disease caused by the parasite Trypanosoma cruzi. Chagas disease is primarily transmitted to humans through contact with the feces of infected triatomine bugs, also known as “kissing bugs,” due to their tendency to bite around the mouth. The disease is most prevalent in rural areas of Latin America, where insects reside in the cracks and holes of poorly constructed houses. Chagas disease can also be transmitted through organ transplantation, blood transfusions, consumption of contaminated food, and congenitally during pregnancy. If the disease is left untreated, it could lead to serious heart and digestive complications [43].

Leishmaniasis is a parasitic illness caused by various species of the protozoan parasite called Leishmania. Sandfly acquire the parasite by feeding on infected animals or humans, Phlebotomus in tropical and subtropical of the Old World and Lutzomyia in the New World [30]. Most sandflies are active during warm, humid nights. Their nocturnal feeding habits pose a greater threat to people sleeping outdoors. During the day, they rest in various hiding places such as cracks in walls, rodent burrows, or inside homes. Sandflies tend to rest on house walls before feeding, and that increases the risk of human infection. Leishmaniasis can be seen in different forms: cutaneous leishmaniasis, mucocutaneous leishmaniasis, and visceral leishmaniasis. Disease manifestations are various from self-healing disease to fatal one. Cutaneous leishmaniasis mainly affects the skin, and symptoms usually are self-healing but can leave disfiguring scars, while visceral leishmaniasis affects internal organs like the spleen, liver, and bone marrow and becomes fatal if left untreated [44]. Leishmaniasis is considered a significant public health concern in many tropical and subtropical regions worldwide [30].

Advertisement

5. Burden of mosquito-borne diseases on Global Health

Given that mosquito-borne diseases have the highest toll globally in terms of mortality and morbidity among all vector-borne diseases, this section will discuss its relevant global burden. Mosquito-borne infections pose the most significant threats to public health, most likely in tropical and subtropical regions. Over 80% of these regions’ global infectious disease burden is centered within endemic areas. The highest toll of malaria’s morbidity and mortality falls upon the vulnerable populations of children under 5 years old, pregnant women, and unimmune travelers to endemic regions [45]. The impact is relatively more on low—and middle-income countries, with a lack of healthcare resources and infrastructure that may create real challenges to battle these diseases effectively [36].

Malaria is the most predominant and devastating mosquito-transmitted disease substantially in sub-Saharan Africa, with 1.5–2.5 million deaths annually [35]. The global economic cost of treatment and prevention programs for malaria increased by around $12 billion annually. The impacts of mosquito-borne diseases extend far beyond the direct health consequences by causing severe socio-economic disruptions in affected regions [33].

Advertisement

6. Factors contributed to the emergence and Re-emergence of vector-borne diseases in recent decades

Different factors, such as climate change, rapid population expansion, random urbanization, and accelerated globalization, significantly contributed to the emergence and re-emergence of vector-borne diseases in recent decades. Tropical areas, including portions of Africa, Southeast Asia, Central America, and South America, have high rates of vector-borne diseases due to their ecosystems, socio-economic conditions, and environmental factors [46].

The dynamic relationship between vector-borne diseases and climate change has been studied extensively and well-documented. Climate plays a vital role in mosquito biology and behavior, influencing host-seeking behavior, flight activity, and population dynamics [46]. Warm temperatures, high humidity, and frequent rainfall create perfect conditions for mosquitoes to breed, develop, and transmit diseases. Those factors guarantee a continuous vector life cycle, allowing for sustained transmission of diseases like mosquitoes and ticks, which usually resurge with proper conditions as a result of vector abundance. Rising temperatures, as an example of climate change, affect the precipitation patterns, which create favorable conditions for the proliferation and geographic expansion of disease-carrying mosquito species in new regions [47].

Biodiversity is abundant in tropical regions due to their distinguished environmental factors and ecosystems. A greater density and diversity of vectors and hosts- both humans and animals- are noticed in such areas, where vectors develop and encounter a variety of pathogens that can subsequently infect humans [48].

Random expansion of urbanization and deforestation in tropical regions disturb the natural ecosystems, leading to changes in the behaviors and habitats of vectors, forcing them to be in closer contact with humans. For example, massive deforestation raises humans’ exposure rate to vector-borne diseases where vectors and their non-human host move closer to human settlements, like in the case of the sand fly, the vector of leishmaniasis, and ticks where deers have been seen more frequently at human residential backyard [46]. Rapid growth urbanization aggravates the spread of mosquito-borne diseases. Many cities worldwide are built with inadequate infrastructures, sanitation, and stagnant water sources, generating perfect habitats for mosquito breeding [49]. Furthermore, globalization facilitates highly frequent international travel, easing the dissemination of vector-borne pathogens, particularly mosquitoes, that are relevant to new regions, causing epidemics and establishing endemic transmission cycles [50].

Socio-economic status is a challenging contributor to vector-borne disease transmission in many tropical and subtropical countries. Poverty, crowded living conditions, limited healthcare resources and access, poor sanitation, lack of clean water sources, inadequate waste disposal, and dilapidated infrastructures expand the transmission pattern of all varieties of diseases and increase the risk of being infected. Tropical and subtropical regions, particularly endemic areas of vector-borne diseases, encounter an added challenge where increased mortality and morbidity rates of these diseases further deteriorate the socio-economic status of affected communities. Infected individuals within endemic communities typically lose their productivity and become incapable of delivering their social duties due to illness, pushing these impacted families lower down in socio-economic status and making it harder for them to break the vicious cycle of poverty where vector-borne diseases thrive. Moreover, the burden of vector-borne diseases morbidity, and mortality, and the associated financial cost governments allocate to mitigate these diseases across different levels cripple the country’s abilities to develop and progress and prolong poverty and poor conditions leading to disease sustainability and endemicity [51, 52, 53].

Advertisement

7. Prevention and control

The diversity of vector species with variable behavioral and biological characteristics, the emergence of their resistance to typical control measures, and the presence of multiple foci in tropical regions led to the necessity of an integrated physical, biological, and chemical vectors mitigation approach, to attain significant impacts and high efficacy control.

Targeting breeding sites and disease foci has been the most productive approach to controlling vector-borne diseases for decades (Figure 8(a and b)). Various physical methods can be applied for breeding site and disease vector foci elimination, including destruction, draining, or filling stagnant water areas, using oil film on aquatic habitats, covering open containers and rain barrels, and removing automobile tires where rainfall water collect and vectors breed. Biological control measures to reduce vector population can be utilized by introducing natural predators of vectors, such as fish-eating mosquito larvae, to open water surfaces like lakes and ponds. Chemical agents such as insecticides and larvicides are typically used to kill larvae and adult mosquitoes. Typical insecticides used in vector control programs include chlorinated (e.g., DDT, BHC, and dieldrin), organic phosphates (e.g., malathion and parathion), carbamates (e.g., Iandrin and bendiocarb), pyrethroids (e.g., permethrin and deltamethrin). These chemical agents can be used in different ways, as aerosols or incorporated into liquid or solid products for vector control [30].

Figure 8.

(a) Mosquito larval collection from a variety of breeding sites for surveillance purposes and (b) mosquito adults’ collection for surveillance purposes using spray-sheet technique [54].

Vector control methods must be designed according to vectors’ characteristics and the nature of breeding sites or disease foci. For example, in the eradication program for malaria, knowing that Anopheles mosquitoes have resting behavior on house walls after blood feeding helped design control measures, including applying insecticides (DDT) to the walls to create direct contact with vectors, resulting in their death. In addition, indoor and outbuilding residual spraying (IRS) acts as a protective barrier (repellent) against vectors entering the house. In addition to insecticide-treated bed nets (ITNs), they are used as personal protective measures from feeding vectors in human settlements. Ongoing surveillance systems are essential for detecting and responding to outbreaks of vector-borne diseases. Further, public health education can raise awareness about vector-borne diseases and promote protective behaviors and practices [30].

It is important to note that insecticides used as vector control measures showed significant impact and contributed effectively to vectors carrying diseases. However, serious problems have been identified that are associated with insecticide usage. Resistance strains to many insecticides have been reported in different affected regions, creating new challenges when controlling the resistance vectors. Poisoning is one of the most severe problems for public health, where more than 500,000 cases are estimated to occur annually due to misapplication or lack of knowledge regarding the toxicity of chemical products utilized in insecticides. Another public health concern is pesticide residue contamination of food, which leads to its unsuitability for use and thus indirectly affects the agricultural economy and the inability to export [30].

7.1 Future research in vector control

Novel vector control interventions have been developed from extensive research in the recent decade. This section will highlight a few innovative measures developed for vector control over the years.

Gene drive is one of the novel control approaches. It is a genetic modification method that spreads favorable traits through interbreeding populations of malaria mosquitoes. This method can be used for virulent population replacement or suppression, by reducing mosquitoes’ ability to transmit a pathogen, reducing female fertility, or biasing the sex ratio toward males (Figure 9) [56].

Figure 9.

Impact of Genetically modified mosquitoes versus Wolbachia-infected mosquitoes on mosquitoes population levels [55].

Another innovative method in vector-borne disease control is introducing Wolbachia bacteria into Aedes mosquitoes, as part of the ‘World Mosquito Program’ that is conducting a randomized controlled trial and programmatic evaluations in several countries worldwide. The method is based on releasing mosquitoes carrying Wolbachia into the field to mate with the wild mosquito population, and over time, the population of mosquitoes carrying Wolbachia increase resulting in transmission reduction of dengue and other arboviruses. Wolbachia infections can reduce the transmission of arboviruses by several mechanisms, including inhibition virus replication within the mosquito, shorting mosquitoes’ lifespan, and creation of cytoplasmic incompatibility phenomena which lead to produce proportion of mosquitoes that are less likely to transmit dengue [57, 58].

Furthermore, eave tubes were developed as a new, promising household protective measure. They are small plastic tubes with insecticide-laden electrostatic netting inserted into the house wall directly below the roof. Mosquitoes are attracted to the house by host odors released through the eave tubes, and then mosquitoes are killed after contacting the insecticide-treated netting. The method is being tested in a large randomized controlled trial in Côte d’Ivoire alongside other house measures such as eave closure and window screening [59, 60].

Lastly, human and livestock treatments such as vaccination and chemoprophylaxis as oral Ivermectin, are promising strategies for controlling and preventing vector-borne diseases. However, further studies are still needed to overcome biological and environmental challenges and problems [31].

Advertisement

8. Conclusion

Vector control is an endless human battle due to environmental, biological, and socio-economic challenges; leaving vector-borne diseases remain as a significant public health challenge in tropical and subtropical regions. Vectors such as mosquitoes, sandflies, and kissing bugs are crucial in transmitting pathogens that cause diseases like malaria, dengue, Zika, Chagas disease, and leishmaniasis. Effective control and prevention of these diseases require a multifaceted integrated approach, including integrated vector control measures, vaccination, public health education, and personal protection measures. As climate change, urbanization, and other factors continue to shape the epidemiology of vector-borne diseases, ongoing research and innovation will be essential to reducing the burden of these diseases on vulnerable populations in tropical regions.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. World Health Organization. Vector-Borne Diseases. WHO; 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases
  2. 2. Arthropod. Merriam-Webster.com Dictionary. Merriam-Webster. Available from: https://www.merriam-webster.com/dictionary/arthropod; [Accessed: September 29, 2024]
  3. 3. European Commission Humanitarian Aid and Civil Protection. Vector Borne Diseases. WEDC. Available from: https://ec.europa.eu/echo/files/evaluation/watsan2005/annex_files/WEDC/evc/evc-02.pdf
  4. 4. Centers for Disease Control and Prevention (CDC). Hantavirus Disease. CDC; 2020. Available from: https://www.cdc.gov/hantavirus/index.html
  5. 5. Rinker DC, Pitts RJ, Zwiebel LJ. Disease vectors in the era of next-generation sequencing. Genome Biology. 2016;17:95. DOI: 10.1186/s13059-016-0966-4
  6. 6. VectorStock. Nature Aedes Egyptian Growth Stage Stilt Mosquito. Available from: https://www.vectorstock.com/royalty-free-vector/nature-aedes-egyptian-growth-stage-stilt-mosquito-vector-33811722
  7. 7. Service MW. Medical Entomology for Students. New York, United States of America: Cambridge University Press; 2012
  8. 8. Gullan PJ, Cranston PS. The Insects: An Outline of Entomology. Malden, MA, USA: Blackwell Publishing Ltd; 2014
  9. 9. Eldridge BF, Edman JD. Medical Entomology: A Textbook on Public Health and Veterinary Problems Caused by Arthropods. Dordrecht: Springer Science+ßusiness Media, Kluwer Academic Publishers; 2004
  10. 10. Lehane MJ. The Biology of Blood-Sucking in Insects. New York, United States of America: Cambridge University Press; 2005
  11. 11. Lewis J, Gallichotte EN, Randall J, Glass A, Foy BD, Ebel GD, et al. Intrinsic factors driving mosquito vector competence and viral evolution: A review. Frontiers in Cellular and Infection Microbiology. 2023;13:1330600
  12. 12. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Research. 1 Feb 2010;85(2):328-345
  13. 13. Vedantu. Mosquito. Vedantu. Available from: https://www.vedantu.com/animal/mosquito
  14. 14. Centers for Disease Control and Prevention (CDC). Malaria. CDC; 2021. Available from: https://www.cdc.gov/malaria/index.html
  15. 15. Muller R, Baker JR. Medical Parasitology. London: Gower Medical Publishing; 1990
  16. 16. Global Vector Hub. Anopheles Mosquitoes. Global Vector Hub; 2024. Available from: https://globalvectorhub.tghn.org/vector-species/anopheles-mosquitoes/
  17. 17. Centers for Disease Control and Prevention (CDC). Public Health Image Library (PHIL)Image 18753. Anopheles gambiae mosquito [Internet]. Available from: https://phil.cdc.gov/Details.aspx?pid=18753
  18. 18. Centers for Disease Control and Prevention (CDC). Public Health Image Library (PHIL) Image 26041. Aedes aegypti mosquito [Internet]. Available from: https://phil.cdc.gov/Details.aspx?pid=26041
  19. 19. Centers for Disease Control and Prevention (CDC). Public Health Image Library (PHIL) Image 4487. Aedes albopictus mosquito [Internet]. Available from: https://phil.cdc.gov/Details.aspx?pid=4487
  20. 20. Global Vector Hub. Aedes Mosquitoes. Global Vector Hub; 2024. Available from: https://globalvectorhub.tghn.org/vector-species/aedes-mosquito/
  21. 21. Centers for Disease Control and Prevention. Life Cycle of Culex Mosquitoes [Internet]. Available from: https://www.cdc.gov/mosquitoes/about/life-cycle-of-culex-mosquitoes.html#cdc_generic_section_2-life-stages
  22. 22. Global Vector Hub. Culex Mosquitoes. Global Vector Hub; 2024. Available from: https://globalvectorhub.tghn.org/vector-species/culex-mosquitoes/
  23. 23. Centers for Disease Control and Prevention (CDC). Ticks. CDC; 2021. Available from: https://www.cdc.gov/ticks/index.html
  24. 24. Centers for Disease Control and Prevention (CDC). Public Health Image Library (PHIL) Image 10277. Phlebotomus papatasi sand fly [Internet]. Available from: https://phil.cdc.gov/Details.aspx?pid=10277
  25. 25. World Health Organization. Leishmaniasis. WHO; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
  26. 26. Centers for Disease Control and Prevention (CDC). Plague. CDC; 2021. Available from: https://www.cdc.gov/plague/index.html
  27. 27. Centers for Disease Control and Prevention (CDC). Signs and Symptoms of Taeniasis. Available from: https://www.cdc.gov/taeniasis/signs-symptoms/index.html [Accessed: October 1, 2024]
  28. 28. World Health Organization. Vector-borne Diseases; n.d. Available from: https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases [Accessed: September 30, 2024]
  29. 29. Walter J, Johan. Medical Parasitology. 3rd ed. USA: Mosby; 1981
  30. 30. Brown HW, Neva FA. Basic Clinical Parasitology. 5th ed. USA: Appleton-Century Crofts; 1983
  31. 31. Despommier D, Griffin D, Gwadz R, Hotez P, Knirsch C. Parasitic Diseases. 7th ed. New York, USA: Parasites Without Borders; 2019
  32. 32. Gubler DJ. Dengue and dengue hemorrhagic fever: Its history and resurgence as a global public health problem. In: Gubler DJ, Kuno G, editors. Dengue and Dengue Hemorrhagic Fever. London, United Kingdom: CAB International; 1997. pp. 1-22
  33. 33. Caminade C, Kovats S, Rocklöv J, Tompkins AM, Morse AP, Colón-González FJ, et al. Impact of climate change on global malaria distribution. National Academy of Sciences. 2014, February 3;111(9):3286-3291. DOI: 10.1073/pnas.1302089111
  34. 34. Rajendran R, Regu K, Anusree S, Rajendran A, Tamizharasu W. Entomological surveillance of Stegomyia mosquitoes in and around Cochin Seaport, Kerala, India. Innovative Journal Solutions. 2022;9(2):132-138. DOI: 10.22271/23487941.2022.v9.i1a.591
  35. 35. Dieme C, Rotureau B, Mitri C. Microbial pre-exposure and vectorial competence of Anopheles mosquitoes. Frontiers in Cellular and Infection Microbiology. 7 Dec 2017;7:508. DOI: 10.3389/fcimb.2017.00508
  36. 36. Bakri RA. Overview of mosquito-borne viral infections in Makkah, Saudi Arabia. Albaha University Journal of Basic and Applied Sciences. 2020;4:15-18
  37. 37. Dengue and Severe Dengue WPRO. 2018. Available from: https://www.who.int/westernpacific/health-topics/dengue-and-severe-dengue
  38. 38. Melebari S, Bakri R, Hafiz A, Qabbani F, Khogeer A, Alharthi I, et al. The epidemiology and incidence of dengue in Makkah, Saudi Arabia, during 2017-2019. Saudi Medical Journal. 2021;42(11):1173-1179. DOI: 10.15537/smj.2021.42.11.20210124
  39. 39. Zika: The origin and spread of a mosquito-borne virus. 2016. Available from: https://www.who.int/publications/m/item/zika-the-origin-and-spread-of-a-mosquito-borne-virus
  40. 40. Bulcha B, Tarafa M, Gassa SLR, Regassa S. Role of vectors and climate change on the epidemiology of Rift Valley fever. Journal of Veterinary Science & Medicine. 2019;7(1):1-7. DOI: 10.13188/2325-4645.1000040
  41. 41. Nichol BHBBST. Breaking the Chain: Rift Valley Fever Virus Control via Livestock Vaccination. 2012. Available from: https://www.sciencedirect.com/science/article/pii/S1879625712000454
  42. 42. Solomon T. Neurological aspects of tropical disease: Japanese encephalitis. BMJ. 2000;68(4):405-415. DOI: 10.1136/jnnp.68.4.405
  43. 43. Sosa-Estáni S, Segura EL. Integrated control of Chagas disease for its elimination as public health problem - A review. Instituto Oswaldo Cruz, Ministério da Saúde. 2015;110(3):289-298
  44. 44. Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, et al. Diagnosis and treatment of leishmaniasis: Clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clinical Infectious Diseases. 14 Nov 2016;63(12):e202-e264
  45. 45. Jadkarim RJA. Malaria determinates and prevention-centered outcomes across data and literature of vulnerable population [dissertaions & thesis]. Tulane University ProQuet; 2022. p. 29164404. Available from: https://www.proquest.com/openview/ddc9c462e302cdc57c63d5940c5f353e/1?pq-origsite=gscholar&cbl=18750&diss=y
  46. 46. Reinhold JM, Lazzari CR, Lahondère C. Effects of the environmental temperature on Aedes aegypti and Aedes albopictus mosquitoes: A review. Multidisciplinary Digital Publishing Institute. 2018;9(4):158-158. DOI: 10.3390/insects9040158
  47. 47. Ogden NH. Climate change and vector-borne diseases of public health significance. FEMS Microbiology Letters. 2017;364:19. DOI: 10.1093/femsle/fnx186
  48. 48. Guernier V, Hochberg M, Guégan J. Ecology drives the worldwide distribution of human diseases. Public Library of Science. 2004;2(6):e141-e141. DOI: 10.1371/journal.pbio.0020141
  49. 49. Patterson-Lomba O, Gómez-Liévano A. On the Scaling Patterns of Infectious Disease Incidence in Cities. arXiv e-prints; 2018. DOI: 10.48550/arxiv.1809.00277
  50. 50. Melebari S, Hafiz A, Alzabeedi KH, Alzahrani AA, Almalki Y, Jadkarim RJ, et al. Malaria during COVID-19 travel restrictions in Makkah, Saudi Arabia. Tropical Medicine and Infectious Disease. 2024;9(5):112. DOI: 10.3390/tropicalmed9050112
  51. 51. Hotez PJ, Bottazzi ME, Strych U. Poverty and the impact of COVID-19: The blue marble health approach. Tropical Medicine and Infectious Disease. 2021;6(2):101. DOI: 10.3390/tropicalmed6020101
  52. 52. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Archives of Medical Research. 2002;33(4):330-342. DOI: 10.1016/s0188-4409(02)00378-8
  53. 53. Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002;415(6872):680-685. DOI: 10.1038/415680a
  54. 54. World Health Organization. Webinar: Dengue Vector Surveillance [Internet]. Available from: https://www.who.int/southeastasia/news/events/detail/2023/09/05/south-east-asia-events/webinar-dengue-vector-surveillance
  55. 55. Yen P-S, Failloux A-B. A review: Wolbachia-based population replacement for mosquito control shares common points with genetically modified control approaches. Pathogens. 2020;9(5):404. DOI: 10.3390/pathogens9050404
  56. 56. Hammond AM, Galizi R. Gene drives to fight malaria: Current state and future directions. Pathogens and Global Health. 2017;111:412-423
  57. 57. Flores HA, O’Neill SL. Controlling vector-borne diseases by releasing modified mosquitoes. Nature Reviews. Microbiology. 2018;16(8):508-518
  58. 58. Anders KL, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Andari B, et al. The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia: Study protocol for a cluster randomised controlled trial. Trials. 2018;19:302
  59. 59. Knols BG, Farenhorst M, Andriessen R, Snetselaar J, Suer RA, Osinga AJ, et al. Eave tubes for malaria control in Africa: An introduction. Malaria Journal. 2016;15:404
  60. 60. Sternberg ED, Cook J, Ahoua Alou LP, Aoura CJ, Assi SB, Doudou DT, et al. Evaluating the impact of screening plus eave tubes on malaria transmission compared to current best practice in Central Côte d’Ivoire: A two-armed cluster randomized controlled trial. BMC Public Health. 2018;18:894

Written By

Rowaida Bakri and Renad J. Jadkarim

Submitted: 01 October 2024 Reviewed: 22 October 2024 Published: 28 January 2025